Vadivarhe Speciality Chemicals Limited

NSEI:VSCL Stock Report

Market Cap: ₹573.9m

Vadivarhe Speciality Chemicals Past Earnings Performance

Past criteria checks 3/6

Vadivarhe Speciality Chemicals has been growing earnings at an average annual rate of 40.6%, while the Chemicals industry saw earnings growing at 14.6% annually. Revenues have been growing at an average rate of 10.3% per year. Vadivarhe Speciality Chemicals's return on equity is 16%, and it has net margins of 1.2%.

Key information

40.6%

Earnings growth rate

40.7%

EPS growth rate

Chemicals Industry Growth17.7%
Revenue growth rate10.3%
Return on equity16.0%
Net Margin1.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Vadivarhe Speciality Chemicals (NSE:VSCL) Takes On Some Risk With Its Use Of Debt

Dec 05
Vadivarhe Speciality Chemicals (NSE:VSCL) Takes On Some Risk With Its Use Of Debt

Here's Why Vadivarhe Speciality Chemicals (NSE:VSCL) Has A Meaningful Debt Burden

Jun 25
Here's Why Vadivarhe Speciality Chemicals (NSE:VSCL) Has A Meaningful Debt Burden

Here's Why Vadivarhe Speciality Chemicals (NSE:VSCL) Can Afford Some Debt

Mar 13
Here's Why Vadivarhe Speciality Chemicals (NSE:VSCL) Can Afford Some Debt

Is Vadivarhe Speciality Chemicals (NSE:VSCL) Using Too Much Debt?

Sep 17
Is Vadivarhe Speciality Chemicals (NSE:VSCL) Using Too Much Debt?

Is Vadivarhe Speciality Chemicals (NSE:VSCL) Using Too Much Debt?

Jun 04
Is Vadivarhe Speciality Chemicals (NSE:VSCL) Using Too Much Debt?

Vadivarhe Speciality Chemicals (NSE:VSCL) Is Carrying A Fair Bit Of Debt

Feb 03
Vadivarhe Speciality Chemicals (NSE:VSCL) Is Carrying A Fair Bit Of Debt

Is Vadivarhe Speciality Chemicals (NSE:VSCL) Using Too Much Debt?

May 18
Is Vadivarhe Speciality Chemicals (NSE:VSCL) Using Too Much Debt?

Health Check: How Prudently Does Vadivarhe Speciality Chemicals (NSE:VSCL) Use Debt?

Dec 29
Health Check: How Prudently Does Vadivarhe Speciality Chemicals (NSE:VSCL) Use Debt?

Revenue & Expenses Breakdown

How Vadivarhe Speciality Chemicals makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:VSCL Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244085540
30 Jun 244073500
31 Mar 244051460
31 Dec 23388-14440
30 Sep 23370-28420
30 Jun 23407-8430
31 Mar 2344311440
31 Dec 22389-20460
30 Sep 22335-54460
30 Jun 22276-75450
31 Mar 22218-96440
31 Dec 21241-77400
30 Sep 21226-57380
30 Jun 21242-41380
31 Mar 21267-28390
31 Dec 20254-12400
30 Sep 20260-51430
30 Jun 20253-107470
31 Mar 20287-98530
31 Dec 19288-116570
30 Sep 19354-66600
30 Jun 19366-2590
31 Mar 193271570
31 Mar 1825918460
31 Mar 1735360400
31 Mar 1626343330
31 Mar 1519040950
31 Mar 141391850

Quality Earnings: VSCL has high quality earnings.

Growing Profit Margin: VSCL became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: VSCL has become profitable over the past 5 years, growing earnings by 40.6% per year.

Accelerating Growth: VSCL has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: VSCL has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (8%).


Return on Equity

High ROE: VSCL's Return on Equity (16%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 06:19
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vadivarhe Speciality Chemicals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution